Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bioservo Technologies AB Interim Report January - June 2020

Second quarter in figures · Net sales SEK 4.8 M (3.5) · EBITDA of SEK -3.8 M (-4.8)  · EBIT of SEK -4.8 M (-5.8) · Earnings for the period was SEK -4.8 M (-5.8) · Earnings per share before and after dilution amounted to SEK -0.34 (-0.65) · Cash flow from operating activities for the period amounted to SEK -6.0 M (-7.4) · At 30 June, cash and cash equivalents were SEK 44.2 M (9.9)  First half-year in figures · Net sales SEK 7.8 M (5.2) · EBITDA of SEK -10.4 M (-9.3) · EBIT of SEK -12.4 M (-11.1) · Earnings for the period was SEK -12,4 M (-11.1)  ·

ExpreS2ion appoints new CFO

Hørsholm, Denmark, August 18, 2020 – ExpreS2ion Biotech Holding AB (“ExpreS2ion” or the “Company”) hereby announces that it has appointed Mr. Keith Alexander as new Chief Financial Officer (CFO). Mr. Alexander brings more than 20 years of corporate banking and strategy consulting experience and will initially be focused on strengthening the Company’s financial strategies and investor relations function. Mr. Alexander will begin his employment on October 1, 2020 and be based out of ExpreS2ion’s headquarters in Hørsholm, Denmark. The appointment of Mr. Alexander follows the strategy

Interim report, January–June 2020

Strengthened balance sheet in a challenging environmentJanuary–June 2020 · Revenue amounted to TSEK 94,559 (109,348). · Operating profit amounted to TSEK -11,958 (-4,389). · Operating profit excluding non-recurring costs amounted to TSEK -11,958 (7,908). · Profit after tax amounted to TSEK -18,186 (8,418). · Earnings per share amounted to -0.51 SEK (0.29). April-June 2020 · Revenue amounted to TSEK 34,983 (55,987). · Operating profit amounted to TSEK -17,313 (-9,049). · Operating profit excluding non-recurring costs amounted to TSEK -17,313 (3,248). ·

Olvi Group's Harf-Year Report, 1 January to 30 June 2020 (6 months)

OLVI PLC                             Half-Year Report 18.8.2020 at 9:00 am   OLVI GROUP’S HALF-YEAR REPORT, 1 JANUARY TO 30 JUNE 2020 (6 MONTHS) Half-year report in brief Olvi Group’s sales volume, net sales and operating profit improved during the review period. Thanks to a strong market position, sales volume and operating profit increased also in the second quarter despite the impacts of the corona pandemic. The financial standing and cash at hand remain at the previous year’s good level. Reinstating the earnings guidance The corona pandemic caused a sudden change in

Nordic Mining ASA (OAX:NOM) - Interim report per 30 June 2020

Enclosed please find Nordic Mining’s interim report and company presentation for the second quarter of 2020. The interim report and company updates will be presented digitally today, Tuesday 18 August 2020 at 10.00 (CET). The presentation and Q&A session will be held in English and transferred via webcast at: https://channel.royalcast.com/webcast/hegnarmedia/20200818_7/ You will have the opportunity to post questions online throughout the webcast session.Important events in the second quarter of 2020 and year to date: CORPORATE Adequately financed well into 2021 In January 2020,

TOPCAB strengthens its presence in Nacka and Värmdö

Cabonline Group has connected about twenty cars from Värmdötaxi and grows hereby in the south eastern archipelago area of Stockholm.The transporters who previously belonged to Värmdötaxi will as of this week drive under the brand TOPCAB. With these new drivers TOPCAB increase its presence in the Stockholm region. - This means that we create a new market for TOPCAB in Nacka and Värmdö, and that travellers can continue to ride with highly appreciated transporters and drivers, says Magnus Klintbäck, CEO Cabonline Stockholm. All drivers are now undergoing training to ensure the same high

Azelio signs agreement with ALEC Energy to set up renewable energy storage site in Masdar City

Azelio will install a verification project in Abu Dhabi in Q3 2020 together with Masdar and Khalifa University. The purpose of the installation is to evaluate Azelio’s energy storage technology for inclusion in the Masdar product portfolio for current and future renewable energy projects. An agreement has now been signed with ALEC Energy to set up the Azelio project site in Masdar city, Abu Dhabi.The preparation for Azelio’s energy storage installation in Abu Dhabi is progressing according to plan. The project has reached an important milestone in a signed agreement with ALEC Energy to

ExpreS2ion provides update on anticipated development of the breast cancer vaccine candidate AV001, including a probable change in its ownership stake in AdaptVac

Hørsholm, Denmark, August 18, 2020 – ExpreS2ion Biotech Holding AB (“ExpreS2ion” or the “Company”) hereby announces that ExpreS2ion wishes to exercise the option to inlicense AV001 before it expires on February 26, 2021. The exercise of the option is subject to the Company obtaining the necessary financing to fund the exercise of the option and the further preclinical development of AV001. If so, the Company expects to be able to submit an application to start clinical trials in the first half of 2022. The Company furthermore announces that it will transfer 16 percent of its joint venture

Imfinzi granted FDA Priority Review for less-frequent, fixed-dose use

18 August 2020 07:00 BST Imfinzi granted FDA Priority Review for less-frequent, fixed-dose use Option would extend dosing to four weeks in non-small cell lungand bladder cancer reducing medical visits by half AstraZeneca's Imfinzi (durvalumab) has received acceptance for its supplemental Biologics License Application (sBLA) and has also been granted Priority Review in the US for a new four-week, fixed-dose regimen for treatment in the approved indications of non-small cell lung cancer (NSCLC) and bladder cancer. If approved, Imfinzi could be administered intravenously every

Unique temples near Bangkok offer out-of-the-ordinary experiences

Temple visits are a highlight of any trip to Thailand.Temple visits are a highlight of any trip to Thailand. The ornate pagodas and golden Buddha images make temples must-see attractions with many options for visitors to choose from. There are several thousand temples dotted around Bangkok alone, making it easy to simply temple-hop in the capital city. But in a country with so many beautiful temples, it’s worth it to venture a little farther afield.Here, we invite visitors to take a step inside some of the most unique temples near Bangkok for an out-of-the-ordinary experience in off-the-

KONE to equip phase two of Chongqing Metro Line 6 in China

KONE Corporation, press release, August 18, 2020  KONE Corporation, a global leader in the elevator and escalator industry, will deliver 83 escalators and 20 elevators to the second phase of the Metro Line 6 in Chongqing, in southwest China.The Line 6 will become an important connection running through the Liangjiang New Area in the north of the city. The Liangjiang New Area and especially its Yuelai district are important hubs bringing together international business, exhibitions and conferences, leisure tourism, cultural creativity, and ecological living. The new metro

Nevisense selected for ‘SpotCheck’ remote melanoma detection evaluation study by The Ronald O. Perelman Department of Dermatology at NYU Langone Health

Stockholm, Sweden and New York, USA - August 18, 2020 - SciBase Holding AB  ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that Nevisense will be included in a large clinical study initiated by The Ronald O. Perelman Department of Dermatology clinic at NYU Langone Health.  The SpotCheck study will investigate the use of Nevisense as a point-of-care diagnostic tool to assist with skin cancer detection in a remote setting such as a non-specialist practice or pharmacy. The study will

IMPACT COATINGS AB (PUBL), INTERIM REPORT APRIL-JUNE 2020

FINANCIAL RESULTS SECOND QUARTER 2020 · Net revenue amounted to SEK 5,016 thousand (22,560) · Total income amounted to SEK 9,726 thousand (17,452) · Operating profit amounted to SEK -6,305 thousand (-4,185) · Operating profit after financial items amounted to SEK -6,305 thousand (-4,191) · Cash flow amounted to SEK -2,299 thousand (-12,413) · Equity-to-assets ratio amounted to 282% (130) · Coating system order backlog at period end amounted to EUR 3,765 thousand (2,084) FINANCIAL RESULTS JANUARY-JUNE 2020 · Net revenue amounted to SEK 10,039 thousand (25,507)

Interim report for the period January 1 - June 30, 2020

During the quarter, Climeon made further progress within geothermal, despite the on-going pandemic. Two new power plants have been commissioned in Japan and the first geothermal order was received in Taiwan. Order intake increased by 67 percent and amounted to SEK 40.9 million. Despite the challenging market situation, Climeon had a positive cash flow from operating activities during the quarter. Total cash and cash equivalents and short-term investments increased by 5 percent and amounted to SEK 100.6 million at the end of the period. April - june · Order intake amounted to SEK 40.

Starbreeze AB (publ) Interim Half-Year Q2 2020 report

Second quarter 2020 · Net sales were SEK 31.3 million (160.0). PAYDAY accounted for SEK 28.1 million (14.4). · EBITDA* amounted to SEK 15.5 million (-25.8). · Amortization and depreciation totalled SEK 10.5 million (22.0). · Costs related to the reconstruction were SEK 3.8 million (12.6). · Loss before tax of SEK -2.2 million (-60.1). · Basic and diluted earnings per share were SEK -0.01 (-0.20). · The summer sale run by digital distribution platform Steam had positive impact on sales during the quarter. First half 2020 · Net sales were SEK 53.3 million (207.8)

Lipidor publishes interim report for H1 2020

Today, Lipidor AB publishes its interim report for the period January - June 2020. The quarterly report is available on the company's website lipidor.se  and in the attached pdf.Summary of the interim report – second quarter 2020 Lipidor has continuous positive ongoing out-licensing discussions with potential licensees. Preperations for initiation of the phase lll-study in AKP02 continues according to plan. The planned study is fully financed from existing funds. The subsidiary Emollivet AB, operational within Animal-

Traumakine Update

Faron Pharmaceuticals Oy (“Faron” or the “Company”)· €2.5 million loan guarantee from Finnvera to further expand IV IFN beta-1a manufacturing process · AGC Biologics selected as new commercial scale manufacturer · COVID-19 trials continue to investigate Traumakine treatment Company announcement, 18 August 2020 at 9.00 AM (EET)Insider information TURKU – FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today provides an update on manufacturing plans for Traumakine, its investigational intravenous (IV)

Interim report Q2 2020

Report period April – June, 2020· Net sales in the quarter amounted to SEK 653 million (708). Reported net sales was 7.7% lower compared with Q2 2019. In constant currencies and adjusted for acquisitions, the organic growth was -11.7%. · EBITDA amounted to SEK 163 million (180), corresponding to an EBITDA margin of 25.0% (25.4). · EBITA amounted to SEK 97 million (120), corresponding to an EBITA margin of 14.8% (17.0). · Profit/loss for the quarter amounted to SEK -119 million (19) and includes unrealized net foreign exchange differences of SEK -77 million (-20), expenses of SEK -

BJÖRN BORG AB INTERIM REPORT JANUARY – JUNE 2020

APRIL 1 – JUNE 30, 2020    · The Group’s net sales increased 4.4 percent to SEK 148.0 million (141.7). Excluding currency effects, sales rose 8.0 percent. · Net sales for own e-commerce increased 77 percent to SEK 20.3 million (11.5). Net sales for own e-commerce and e-tailers amounted to SEK 50.1 million (31.6), an increase of 58 percent. · The gross profit margin was 49.1 percent (55.4). · The operating loss amounted to SEK –13.4 million (–1.7). · The loss after tax amounted to SEK –18.8 million (–2.3). · Earnings per share before and after dilution amounted to SEK –0.

BEWiSynbra Group AB (publ) announces its intention to apply for the group to be admitted to trading on Merkur Market

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.BEWiSynbra Group AB (publ) (“BEWiSynbra”), a leading international provider of insulation and packaging solutions, today announces its intention to apply for the shares in a newly established Norwegian parent company, BEWi ASA (together with BEWiSynbra “BEWI”), to be admitted to trading on Merkur Market, a multilateral trading facility operated by

Asetek – Update to Full Year 2020 Guidance

August 18, 2020 – Asetek today updated its full-year 2020 revenue and pre-tax profit expectations due to continued strong demand for Gaming and Enthusiast products and corresponding recent improvements in supply chain capabilities that enable this demand to be serviced. Asetek expects to report an increase in Group revenue of 15% to 25% in 2020 compared with 2019. Gross margin is expected to increase from 2019, and the Company expects an income before tax of about $7-8 million.  This is the second update to full-year expectations published by the Company in 2020. The previous

Increased revenue and EBIT in the second quarter

Zalaris ASA, the provider of Payroll and HR Solutions, today posted second quarter adj. EBIT of 12.7 million, an increase of 72% from last year.Key financial figures for Q2: · Revenue of NOK 198.4 million (NOK 187.5 million), an increase of 5.8% from last year · Adjusted EBIT of NOK 12.7 million (NOK 7.4 million), an increase of 71.6% · Results for the period of NOK 22.4 million (NOK -3.3 million) · Cash of NOK 129.0 million (NOK 59.6 million), an increase of NOK 69.4 million (116.4%) from last year Continuing positive development in margins and cash · Proactively and

Anna Reuterskiöld appointed Partner, Head of CapMan Real Estate Sweden

CapMan Real Estate press release 18 August 2020 at 7.00 am CEST Anna Reuterskiöld appointed Partner, Head of CapMan Real Estate Sweden Anna Reuterskiöld has been appointed Head of CapMan Real Estate Sweden and promoted to Partner. She started with CapMan in 2014, before which she worked as a Property Developer and Analyst for Skanska Fastigheter. “In recognition of her huge contribution to the business since 2014, as well as her dedication, initiative, productivity and leadership qualities, I am delighted to announce that Anna will become the Country Head for CapMan Real Estate

There are no items matching the current filter
There are no more items matching the current filter
Back to top